LEVONORGESTREL AND ETHINYL ESTRADIOL
ETHINYL ESTRADIOL; LEVONORGESTREL
Approval overview LEVONORGESTREL AND ETHINYL ESTRADIOL is listed in Drugs@FDA under application 212298 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ETHINYL ESTRADIOL; LEVONORGESTREL Form and strength TABLET;ORAL-28 - 0.02MG;0.1MG Sponsor HETERO LABS Submission history Latest submission status date: 2023-02-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview LEVONORGESTREL AND ETHINYL ESTRADIOL is listed in Drugs@FDA under application 212298 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ETHINYL ESTRADIOL; LEVONORGESTREL Form and strength TABLET;ORAL-28 - 0.02MG;0.1MG Sponsor HETERO LABS Submission history Latest submission status date: 2023-02-13 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.